Gentamicin ototoxicity: A 23-year selected case series of 103 patients

Medical Journal of Australia

Volumn 196, Issue 11, 2012, Pages 701-704

  Ahmed, Rebekah M ^a   Hannigan, Imelda P ^a   MacDougall, Hamish G ^b   Chan, Raymond C ^a   Michael Halmagyi, G ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUDIOMETRY; BALANCE IMPAIRMENT; CASE STUDY; DELAYED DIAGNOSIS; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOAM ROMBERG TEST; HEAD IMPULSE TEST; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; OSCILLOPSIA; OTOTOXICITY; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT DURATION; VERTICAL HEAD SHAKING TEST; VESTIBULAR DISORDER; VESTIBULAR TEST; ADOLESCENT; AUSTRALIA; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; KIDNEY DISEASE; MIDDLE AGED; PRACTICE GUIDELINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; DELAYED DIAGNOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENTAMICINS; GUIDELINE ADHERENCE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; VESTIBULAR DISEASES;

EID: 84875291356     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.10850     Document Type: Article

References (34)

1. Dobie RA, Black FO, Pezsnecker SC, Stallings VL. Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy. Arch Otolaryngol Head Neck Surg 2006; 132: 253-257.
2. Seemungal BM, Bronstein AM. Aminoglycoside ototoxicity: vestibular function is also vulnerable. BMJ 2007; 335: 952.
3. Halmagyi GM, Fattore CM, Curthoys IS, Wade S. Gentamicin vestibulotoxicity. Otolaryngol Head Neck Surg 1994; 111: 571-574.
4. Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotol 2004; 25: 559-569.
5. Ishiyama G, Ishiyama A, Kerber K, Baloh RW. Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex. Acta Otolaryngol 2006; 126: 1057-1061.
6. Ariano RE, Zelenitsky SA, Kassum D. Aminoglycoside-induced vestibular injury: maintaining a sense of balance. Ann Pharmacother 2008; 42: 1282-1289.
7. Minor LB. Gentamicin-induced bilateral vestibular hypofunction. JAMA 1998; 279: 541-544.
8. Zingler VC, Cnyrim C, Jahn K, et al. Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 2007; 61: 524-532.
9. Weber KP, Aw ST, Todd MJ, et al. Horizontal head impulse test detects gentamicin vestibulotoxicity. Neurology 2009; 72: 1417-1424.
10. Vital D, Hegemann SC, Straumann D, et al. A new dynamic visual acuity test to assess peripheral vestibular function. Arch Otolaryngol Head Neck Surg 2010; 136: 686-691.
11. Vereeck L, Truijen S, Wuyts FL, Van de Heyning PH. The dizziness handicap inventory and its relationship with functional balance performance. Otol Neurotol 2007; 28: 87-93.
12. Halmagyi GM, Yavor RA, McGarvie LA. Testing the vestibulo-ocular reflex. Adv Otorhinolaryngol 1997; 53: 132-154.
13. Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited, 2010.
14. Herdman SJ. Vestibular rehabilitation. 3rd ed. New York: Davis, 2007: 309-359.
15. Gates, GA, Cooper JC, Kannel WB, Miller NJ. Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear 1990; 11: 247-256.
16. Pearson JD, Morrell CH, Gordon-Salant S, et al. Gender differences in a longitudinal study of age-associated hearing loss. J Acoust Soc Am 1995; 97: 1196-1205.
17. Sha SH, Qiu JH, Schacht J. Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med 2006; 354: 1856-1857.
18. Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 1984; 149: 23-30.
19. Lancaster JL, Mortimore S, McCormick M, Hart CA. Systemic absorption of gentamicin in the management of active mucosal chronic otitis media. Clin Otolaryngol Allied Sci 1999; 24: 435-439.
20. Stavroulaki P, Apostolopoulos N, Dinopoulou D, et al. Otoacoustic emissions - an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 1999; 50: 177-184.
21. JC. Living without a balancing mechanism. N Engl J Med 1952; 246: 458-460.
22. MacDougall HG, Weber KP, McGarvie LA, et al. The video head impulse test: diagnostic accuracy in peripheral vestibulopathy. Neurology 2009; 73: 1134-1141.
23. Gentamicin Information Center. About gentamicin poisoning. http://www.gentamicin.com (accessed Mar 2012).
24. Appel GB. Aminoglycoside nephrotoxicity. Am J Med 1990; 88: 16S-20S.
25. Prins JM, Buller HR, Kuijper EJ, et al. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341: 335-339.
26. Raveh D, Koypt M, Hite Y, et al. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM 2002; 95: 291-297.
27. English WP, Williams MD. Should aminoglycoside antibiotics be abandoned? Am J Surg. 2000; 180: 512-515.
28. Leong CL, Buising K, Richards M, et al. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital. Intern Med J 2006; 36: 37-42.
29. Dunagan WC, Woodward RS, Medoff G, et al. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991; 13: 405-412.
30. Johnson MW, Mitch WE, Heller AH, Spector R. The impact of an educational program on gentamicin use in a teaching hospital. Am J Med 1982; 73: 9-14.
31. Wu WJ, Sha SH, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 2002; 7: 171-174.
32. Chen FQ, Schacht J, Sha SH. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. J Neurochem 2009; 108: 1226-1236.
33. Black FO, Gianna-Poulin C, Pesznecker SC. Recovery from vestibular ototoxicity. Otol Neurotol 2001; 22: 662-671.
34. Ahmed RM, MacDougall HG, Halmagyi GM. Unilateral gentamicin vestibulotoxicity. Otol Neurotol 2011; 32: 1158-1162.